Calcium and Protein Kinase C Mediate High-Glucose-Induced Inhibition of Inducible Nitric Oxide Synthase in Vascular Smooth Muscle Cells

Hypertension

Volumn 31, Issue 1, 1998, Pages 289-295

  Muniyappa, Ranganath ^a   Srinivas, Pothur R ^a   Ram, Jeffrey L ^a   Walsh, Mary F ^a   Sowers, James R ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIMYCIN; CALCIUM; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; PROTEIN KINASE C; STAUROSPORINE; THAPSIGARGIN; 1,2-BIS(2-AMINOPHENOXY)ETHANE-N,N,N',N'-TETRAACETIC ACID; CHELATING AGENT; DRUG DERIVATIVE; EGTAZIC ACID; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; ISOENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CALCIUM CELL LEVEL; CELL ADHESION; CELL PROLIFERATION; DRUG EFFECT; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL MEMBRANE; CYTOLOGY; ENZYMOLOGY; KINETICS; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; THORACIC AORTA; TIME;

ANIMALS; AORTA, THORACIC; CALCIUM; CELL MEMBRANE; CELLS, CULTURED; CHELATING AGENTS; EGTAZIC ACID; ENZYME INDUCTION; GLUCOSE; INTERLEUKIN-1; ISOENZYMES; KINETICS; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0031602110     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.31.1.289     Document Type: Article

References (46)

1. Knowles RG, and Moncada S. Nitric oxide synthases in mammals. Biochem J. 1994;298:249-258.
2. Nathan C, and Xie Q. Nitric oxide synthases: roles, tolls, and controls. Cell. 1994;78:915-918.
3. Kanno K, Hirata Y, Imai T, Marumo F. Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension. 1993;22:34-39.
4. Libby P, and Hannson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest. 1991;64:5-11.
5. Buttery LD, Springall DR, Chester AH, Evans TJ, Stanfield EN, Parums DV, Yacoub MH, Polak JM. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 1996;75:77-85.
6. Joly GA, Schini VB, Vanhoutte PM. Balloon injury and interleukin-1 induce nitric oxide synthase activity in rat carotid arteries. Circ Res. 1992;71:331-338.
7. Hansson GK, Geng Y, Holm J, Hardhammar P, Wennmalm A, Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med. 1994;180:733-738.
8. Garg UC, and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
9. Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA. 1990;87:5193-5197.
10. Bath PMW, Hassall DG, Gladwin AM, Palmer RMJ, Martin JF. Nitric oxide and prostacyclin: divergence of inhibitory effects of monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb. 1991;11:254-260.
11. Khan BV, Harrison DG, Olbrych M, Alexander RW, Medford RM. Nitric oxide regulates cell adhesion molecule gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci USA. 1996;93:9114-9119.
12. Sowers JR, and Epstein M. Diabetes mellitus and associated hypertension, vascular disease and nephropathy. Hypertension. 1995;26:869-879.
13. The Diabetes Control, and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
14. Ruderman NB, Williamson JR, Brownlee M. Glucose and diabetic vascular disease. FASEB J. 1992;6:2905-2914.
15. Hein KD, and King GL. Vascular abnormalities in diabetes mellitus. In: Sowers JR (ed) Endocrinology of the Vasculature. Totowa, NJ: Humana Press; 1996:135-144.
16. Levy J, Gavin JR, Sowers JR. Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med. 1994;96:260-273.
17. Standley PR, Zhang F, Zayas RM, Muniyappa R, Walsh MF, Cragoe E, Sowers JR. IGF-I regulation of Na-K-ATPase in rat arterial smooth muscle. Am J Physiol. 1997;273:E113-E121.
18. Muniyappa R, Walsh MF, Rangi JS, Zayas RM, Standley PR, Ram JL, Sowers JR. Insulin like growth factor 1 increases vascular smooth muscle nitric oxide production. Life Sci. 1997;61:925-931.
19. Berti L, Mosthaf L, Kroder G, Kellerer M, Tippmer S, Mushack J, Seffer E, Seedorf K, Haring H. Glucose-induced translocation of protein kinase C isoforms in rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase. J Biol Chem. 1994;269:3381-3386.
20. Chakrarvarthy BR, Bussey A, Whitfield JF, Sikorska M, Williams RE, Durkin JP. The direct measurement of protein kinase C (PKC) activities in isolated membranes using a selective peptide substrate. Anal Biochem. 1991;196:144-150.
21. Nakane M, Klinghofer V, Kuk JE, Donelly JL, Budzik GP, Pollock JS, Basha F, Carter GW. Novel potent and selective inhibitors of inducible nitric oxide synthase. Mol Pharmacol. 1995;47:831.
22. Forstermann U, Gath I, Schwarz P, Closs EI, Kleinert H. Isoforms of nitric oxide synthase: properties, cellular distribution and expressional control. Biochem Pharmacol. 1995;50:1321-1332.
23. Wolf BA, Williamson JR, Easom RA, Chang K, Sherman WR, Turk J. Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest. 1991;87:31-38.
24. Williams B, and Schrier RW. Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes. 1992;41:1464-1472.
25. Haller H, Baur E, Quass P, Behrend M, Lindschau C, Distler A, Luft FC. High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. Kidney Int. 1995;47:1057-1067.
26. Inoguchi T, Xia P, Kunisaki M, Higashi S, Feener EP, King GL. Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol. 1994;267:E369-E379.
27. +. Kidney Int. 1992;41:778-788.
28. Hortelano S, Genaro AM, Bosca L. Phorbol esters induce nitric oxide synthase and increase arginine flux in cultured peritoneal macrophages. FEBS Lett. 1993;320:135-139.
29. Muhl H, and Pfeilschifter J. Possible role of protein kinase C-epsilon isoenzyme in inhibition of interleukin 1 beta induction of nitric oxide synthase in rat mesangial cells. Biochem J. 1994;303:607-612.
30. Paul A, Doherty K, Plevin R. Differential induction of protein kinase C isoforms of nitric oxide synthase induction in RAW 264.7 macrophages and rat aortic smooth muscle cells. Br J Pharmacol. 1997;120:940-946.
31. Geng Y, Wu Q, Hansson GK. Protein kinase C activation inhibits cytokine-induced nitric oxide synthesis in vascular smooth muscle cells. Biochim Biophys Acta. 1994;1223:125-132.
32. Barbagallo M, Shan J, Pang PKT, Resnick LM. Glucose-induced alterations of cytosolic free calcium in cultured rat tail artery vascular smooth muscle cells. J Clin Invest. 1995;95:763-767.
33. Kuriyama S, Tokudome G, Tomonari H, Utsunomiya Y, Matsui K, Hashimoto T, Sakai O. Differential regulation of cation transport of vascular smooth muscle cells in a high glucose concentration milieu. Diabetes Res Clin Pract. 1994;24:77-84.
34. Bading H, Hardingham GE, Johnson CM, Chawla S. Gene regulation by nuclear and cytoplasmic signals. Biochem Biophys Res Commun. 1997;236:541-543.
35. Geng Y, Lotz M. Increased intracellular calcium selectively supresses IL-1-induced NO production by reducing iNOS mRNA stability. J Cell Biol. 1995;129:1650-57.
36. Preston SF, Berlin RD. An intracellular calcium store regulates protein synthesis in HeLa cells, but it is not the hormone-sensitive store. Cell Calcium. 1992;13:303-312.
37. 2+ pool in pancreatic acini. J Biol Chem. 265;2011-2016.
38. Nishio E, and Watanabe Y. Glucose-induced down-regulation of NO production and inducible NOS expression in cultured rat aortic vascular smooth muscle cells: role of protein kinase C. Biochem. Biophys. Res. Commun. 1996;229:857-863.
39. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA. 1992;89:11059-11063.
40. Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S, King GL. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol. 1993;265:E783-E793.
41. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science. 1996;272:728-731.
42. Travis SF, Morrison AD, Clements RS, Winegrad AI, Oski FA. Metabolic alterations in the human erythrocyte produced by increases in glucose concentration: the role of the polyol pathway. J Clin Invest. 1971;50:2104-2112.
43. Asaoka Y, Oka M, Yoshida K, Nishizuka Y. Metabolic rate of membrane-permeant diacylglycerol and its relation to human resting T-lymphocyte activation. Proc Natl Acad Sci USA. 1991;88:8681-8685.
44. 2+) -inhibited bone resoption. Endocrinology. 1997;138:2148-2162.
45. Sharma K, Danoff TM, DePiero A, Ziyadeh FN. Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation via protein kinase C. Biochem Biophys Res Commun. 1995;207:80-88.
46. 1 receptor gene regulation in cardiac myocytes and fibroblasts. Mol Cell Cardiol. 1996;28:1727-1736.